Trials / Completed
CompletedNCT03197441
Platelet Rich Plasma for Knee Osteoarthritis
Intraoperative Platelet Rich Plasma Injection in Arthroscopic Surgery for Osteoarthritis of the Knee
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Pei-Yuan Lee, MD · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to analyze the effect of platelet-rich plasma (PRP) on knee osteoarthritis. Eligible patients will undertake arthroscopic knee surgery plus intraoperative PRP and also receive second look surgery and intraoperative biopsy.
Detailed description
Osteoarthritis is a chronic disease defined by progressive degradation of the joint as well as loss of cartilage on joint surfaces. The degeneration that occurs in the joint leads to changes in the catabolic and anabolic activity of chondrocytes. Osteoarthritis may induce pain, stiffness and limitation in range of motion of the joint and also may impact the quality of life. Platelet-rich plasma (PRP) is a fraction of plasma that contains platelets and multiple growth factors concentrated at high level. Because activated platelets have the potential to release growth factors, PRP has been clinically used to accelerate wound healing and tissue regeneration in orthopedic and oral surgery. Although several studies have assessed the effects of PRP on knee osteoarthritis, a higher level of evidence has not been provided. This study aimed to analyze the effect of PRP on knee osteoarthritis. After performing arthroscopic knee surgery plus intraoperative PRP in eligible patients, a second look arthroscopic surgery with intraoperative biopsy will be arranged 6 months later. Pre- and post-operative imaging and clinical outcomes will also be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Platelet-rich plasma | Intraoperative platelet-rich plasma injection during arthroscopic knee surgery |
Timeline
- Start date
- 2016-08-29
- Primary completion
- 2018-06-28
- Completion
- 2018-06-28
- First posted
- 2017-06-23
- Last updated
- 2019-09-06
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03197441. Inclusion in this directory is not an endorsement.